FPA
ASBP

First Pacific Advisors’s Aspire Biopharma ASBP Stock Holding History

First Pacific Advisors’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47
Closed -$628K – 77
2024
Q1 		$628K Buy
+47
New +$618K 0.01% 57

Other funds holding ASBP

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Pacific Advisors's ASBP Position: Q2 2024 in Review

First Pacific Advisors sold out of Aspire Biopharma (ASBP) in Q2 2024, closing a stake of 47 shares — an estimated $628K sold.

First Pacific Advisors first reported a position in ASBP in Q1 2024 and held it in 1 quarter. The position peaked at $628K in Q1 2024. 3 funds tracked by Wall St. Rank hold ASBP as of Q2 2024.

  • First Pacific Advisors reported no remaining Aspire Biopharma position as of Q2 2024 after selling out during the quarter.
  • First Pacific Advisors sold 47 Aspire Biopharma shares in Q2 2024, an estimated $628K.
  • First Pacific Advisors first reported a position in Aspire Biopharma in Q1 2024 and held it in 1 quarter.
  • First Pacific Advisors's Aspire Biopharma position peaked at $628K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2024.

Based on First Pacific Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.